Roeland Nusse
Founder of Surrozen, Inc., Roeland Nusse is on the board of Bio-Techne Corp. and Professor at Stanford University.
In the past Dr. Nusse held the position of Member of The Royal Netherlands Academy of Arts & Sciences, Member of European Molecular Biology Organization, Head-Molecular Biology & Staff Scientist at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh and Member of American Academy of Arts & Sciences.
Dr. Nusse received an undergraduate degree from the University of Amsterdam and a doctorate from Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh.
Transactions
Date
Transaction
Value
| 02/08/2021 | 6,000 | Disposition at $385.08 per share. | 2,310,480 |
| 02/08/2021 | 5,000 | Derivative/Non-derivative trans. at $66.9 per share. | 334,500 |
| 02/08/2021 | 1,000 | Derivative/Non-derivative trans. at $70.35 per share. | 70,350 |
| 10/29/2020 | 391 | Award at $0 per share. | 0 |
| 11/25/2019 | 8,347 | Disposition at $219.33 per share. | 1,830,748 |
| 11/25/2019 | 5,000 | Derivative/Non-derivative trans. at $61.46 per share. | 307,300 |
| 11/25/2019 | 10,000 | Derivative/Non-derivative trans. at $60.46 per share. | 604,600 |
| 10/24/2019 | 495 | Award at $0 per share. | 0 |
| 10/25/2018 | 514 | Award at $0 per share. | 0 |
| 10/26/2017 | 739 | Award at $0 per share. | 0 |
| 10/27/2016 | 914 | Award at $0 per share. | 0 |
